PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, University Hospital of Heidelberg.\', \'Department of Pharmacy, Heidenheim General Hospital.\', \'Department of Anesthesiology and Intensive Care Medicine, Heidenheim General Hospital.\', \'Department of Anesthesiology and Intensive Care Medicine, Heidenheim General, Heidenheim, Germany.\', \'University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland.\', \'Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women\'s Hospital, Brisbane, Australia.\', \'Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000026253
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34087915
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all